J Virol Methods

J Virol Methods

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

400

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 400 Papers
Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement…

Filippatos F, Tatsi EB, Papagiannopoulos C, Syriopoulou V, Michos A.

2023 PMID: 37028561
3/7
COI Funding
3/7
COI Funding
Development of a validated molecular analytical method to determine the viral safety of F(AB´)<sub>2</sub> products: A …

Sánchez-Pacheco UA, Bahena-Mondragón BM, Hernández-Piedras FR, Soria-Osorio R, Meneses-Acosta A.

2023 PMID: 36822561
4/7
Data COI Funding
Evaluation of a novel anterior nasal swab for the detection of SARS-CoV-2.

Crowe A, Lorenzo YP, Jardine D, Visvanathan K.

2023 PMID: 36934898
3/7
COI Funding
Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.

Kami W, Kinjo T, Hashioka H, Arakaki W, Uechi K, Takahashi A, Oki H, Tanaka K, Motooka D, Nakamura …

2023 PMID: 36796678
2/7
COI
Potential use of high-resolution melting analyses for SARS-CoV-2 genomic surveillance.

de Souza Andrade A, Freitas EF, de Castro Barbosa E, Guimarães NR, de Melo Iani FC, da Costa AVB, B…

2023 PMID: 37116586
4/7
Data COI Funding
Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants.

Andrade IA, Franca LV, Kauffmann CM, Maeda MHK, Koyama LHH, Hamann PRV, Lopes-Luz L, Fogaça MBT, Ca…

2023 PMID: 36914098
3/7
COI Funding
β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for …

Pilchová V, Prajeeth CK, Jendrny P, Twele F, Meller S, Pink I, Fathi A, Addo MM, Volk HA, Osterhaus…

2023 PMID: 37068591
3/7
COI Funding
A robust, cost-effective and widely applicable whole-genome sequencing protocol for capripoxviruses.

Mathijs E, Haegeman A, De Clercq K, Van Borm S, Vandenbussche F.

2022 PMID: 35032481
4/7
Data COI Funding